Alnylam Pharma (ALNY) Tops Q4 EPS by 19c, Beats on Revenues

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/21/2026

1. SPCX
2. NVDA
3. NFLX
4. ISRG
5. TSLA
6. META
7. RTX
8. SMCI
9. GOOGL
10. S

Go back to Alnylam Pharma (ALNY) Tops Q4 EPS by 19c, Beats on Revenues

Alnylam Pharmaceuticals (ALNY) PT Lowered to $160 at BMO Capital

February 8, 2018 12:41 PM EST

BMO Capital lowered its price target on Alnylam Pharmaceuticals (NASDAQ: ALNY) to $160.00 (from $165.00) while maintaining an Outperform rating.

Analyst Do Kim commented, "Alnylam reported 4Q17 GAAP EPS of ($1.48), below our ($1.28) estimate and Street's ($1.38). The wider loss was driven by higher expenses due to... More